CAMBRIDGE, Mass., Nov. 2, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, announced today that management will host a conference call on Monday, November 9, 2009 at 4:30 p.m. EST. In the conference call, management will review recent research and development and business highlights and Infinity's third quarter 2009 financial results.
To participate in the conference call, please dial 1-888-359-3613 (domestic) and 1-719-457-2657 (international) five minutes prior to start time. A live webcast of the conference call, including the presentation slides, can be accessed in the Investors/Media section of Infinity's website at www.infi.com. An archived version of the webcast will be available on Infinity's website for 30 days.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative cancer drug discovery and development company seeking to discover, develop, and deliver to patients best-in-class medicines for the treatment of cancer and related conditions. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging cancer pathways. Infinity's two most advanced programs in Hsp90 chaperone inhibition and Hedgehog signaling pathway inhibition are evidence of its innovative approach to oncology drug discovery and development. For more information on Infinity, please refer to the company's website at http://www.infi.com.